TY - JOUR
T1 - Postoperative Course of Serum Albumin Levels and Organ Dysfunction After Liver Transplantation
AU - Hiroi, Kazumasa
AU - Matsusaki, Takashi
AU - Kaku, Ryuji
AU - Umeda, Yuzo
AU - Yagi, Takahito
AU - Morimatsu, Hiroshi
N1 - Publisher Copyright:
© 2019 The Authors
PY - 2019/10
Y1 - 2019/10
N2 - Background and aims: Postoperative hypoalbuminemia, especially following liver transplantation, can lead to adverse multisystem effects and even death. We investigated the relationship between postoperative albumin levels and organ failure (assessed using Sequential Organ Failure Assessment [SOFA] scores). Methods: Sixty liver transplant recipients admitted to the intensive care unit (ICU) from 2012 to 2015 were retrospectively divided into 2 groups: lower albumin (LA) (n=28) and higher albumin (HA) (n=32), using whether serum albumin level fell below 3.0 g/dL during the first postoperative week as the stratifying factor. The SOFA scores (primary endpoint) and associated complications (ascites amount, rejection, re-intubation, abdominal re-operation, thrombosis), additional treatment (dialysis, pleural effusion drainage), and duration of ICU stay (secondary endpoints) of the 2 groups were compared. Results: Average serum albumin levels were significantly different between HA and LA groups (3.6 [3.4–3.8] vs 3.1 [2.9–3.3], respectively, P <.05), although the amounts of albumin infused in the 2 groups during the first postoperative week were not different (HA vs LA: 42 [30–71] vs 40 [30–58], respectively, P =.37). Mean daily SOFA scores were not significantly different between the HA and LA groups (8.3 [6.6–9.0] vs 7.2 [6.3–8.6], P =.73), although the HA group had lower mean cardiovascular SOFA sub-scores than the LA group (0.1 [0–0.4] vs 0.4 [0–1.3], P =.032). There were no significant differences between the groups with regard to complication rates and duration of ICU and hospital stays. Conclusions: Serum albumin level might not influence cumulative organ function, but it decreases the amount of hemodynamic support required in liver transplant recipients.
AB - Background and aims: Postoperative hypoalbuminemia, especially following liver transplantation, can lead to adverse multisystem effects and even death. We investigated the relationship between postoperative albumin levels and organ failure (assessed using Sequential Organ Failure Assessment [SOFA] scores). Methods: Sixty liver transplant recipients admitted to the intensive care unit (ICU) from 2012 to 2015 were retrospectively divided into 2 groups: lower albumin (LA) (n=28) and higher albumin (HA) (n=32), using whether serum albumin level fell below 3.0 g/dL during the first postoperative week as the stratifying factor. The SOFA scores (primary endpoint) and associated complications (ascites amount, rejection, re-intubation, abdominal re-operation, thrombosis), additional treatment (dialysis, pleural effusion drainage), and duration of ICU stay (secondary endpoints) of the 2 groups were compared. Results: Average serum albumin levels were significantly different between HA and LA groups (3.6 [3.4–3.8] vs 3.1 [2.9–3.3], respectively, P <.05), although the amounts of albumin infused in the 2 groups during the first postoperative week were not different (HA vs LA: 42 [30–71] vs 40 [30–58], respectively, P =.37). Mean daily SOFA scores were not significantly different between the HA and LA groups (8.3 [6.6–9.0] vs 7.2 [6.3–8.6], P =.73), although the HA group had lower mean cardiovascular SOFA sub-scores than the LA group (0.1 [0–0.4] vs 0.4 [0–1.3], P =.032). There were no significant differences between the groups with regard to complication rates and duration of ICU and hospital stays. Conclusions: Serum albumin level might not influence cumulative organ function, but it decreases the amount of hemodynamic support required in liver transplant recipients.
UR - http://www.scopus.com/inward/record.url?scp=85072578380&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072578380&partnerID=8YFLogxK
U2 - 10.1016/j.transproceed.2019.01.199
DO - 10.1016/j.transproceed.2019.01.199
M3 - Article
C2 - 31563245
AN - SCOPUS:85072578380
SN - 0041-1345
VL - 51
SP - 2750
EP - 2754
JO - Transplantation Proceedings
JF - Transplantation Proceedings
IS - 8
ER -